I wrote about financial compensation for patient research advocates when working with pharmaceutical companies and various cancer organizations last year (https://wordpress.com/post/prevailingwithlungcancer.blog/1036). Now, it’s the turn of the patient advocates to do our part – the patients have to be trained. https://lungcancer.net/living/financial-compensation
